Chiasma Stock Price, News & Analysis
Company Description
Chiasma (NASDAQ: CHMA) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $237.8M.
CHMA stock has declined 20.5% over the past year.
This page provides a comprehensive overview of CHMA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Chiasma (CHMA) stock. Over the past 12 months, the stock has lost 20.5%. At a market capitalization of $237.8M, CHMA is classified as a micro-cap stock with approximately 63.2M shares outstanding.
Latest News
Chiasma has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include management, clinical trial, conferences, acquisition, earnings. View all CHMA news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CHMA Company Profile & Sector Positioning
Chiasma (CHMA) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.